Stay updated on PembROlizuMab vs Chemo in MPM Clinical Trial
Sign up to get notified when there's something new on the PembROlizuMab vs Chemo in MPM Clinical Trial page.

Latest updates to the PembROlizuMab vs Chemo in MPM Clinical Trial page
- Check5 days agoChange DetectedThe 403 Forbidden page content and the Home link were removed from the page. This eliminates the error-state text that previously appeared when access was denied.SummaryDifference0.5%

- Check12 days agoChange DetectedThe study details page now displays a 403 Forbidden page instead of the study content. This blocks access to the study overview, documents, locations, and related resources.SummaryDifference19%

- Check19 days agoChange DetectedThe page's revision tag updated from v3.6.6 to v3.7.0, reflecting a site update that does not affect the presented study information.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a small editorial/backend update to the ClinicalTrials.gov entry that does not alter the study data.SummaryDifference0.0%

- Check40 days agoChange DetectedThe study record was updated with administrative documentation changes: a 2016 NIH grant/contract note was added, and a 1.84 MB document size entry was included on 2026-08-24, while older document size references (1.09 MB) and earlier update dates (2022-08-24, 2022-08-23) were removed.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page's revision tag was updated to v3.6.5, reflecting a small software update rather than changes to the study details.SummaryDifference0.0%

Stay in the know with updates to PembROlizuMab vs Chemo in MPM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PembROlizuMab vs Chemo in MPM Clinical Trial page.